HK Stock MarketDetailed Quotes

01548 GENSCRIPT BIO

Watchlist
  • 10.920
  • -0.080-0.73%
Market Closed Nov 12 16:08 CST
23.25BMarket Cap-16825P/E (TTM)

GENSCRIPT BIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
43.46%561.37M
34.17%839.53M
26.40%391.31M
27.67%625.7M
34.86%309.59M
25.39%490.1M
37.97%229.57M
42.98%390.85M
36.53%166.39M
18.33%273.35M
Operating income
43.46%561.37M
34.17%839.53M
26.40%391.31M
27.67%625.7M
34.86%309.59M
25.39%490.1M
37.97%229.57M
42.98%390.85M
36.53%166.39M
18.33%273.35M
Cost of sales
-17.63%-254.39M
-33.69%-429.98M
-53.28%-216.26M
-54.94%-321.62M
-55.13%-141.09M
-53.82%-207.58M
-56.21%-90.95M
-45.01%-134.95M
-35.46%-58.22M
-28.40%-93.06M
Operating expenses
-17.63%-254.39M
-33.69%-429.98M
-53.28%-216.26M
-54.94%-321.62M
-55.13%-141.09M
-53.82%-207.58M
-56.21%-90.95M
-45.01%-134.95M
-35.46%-58.22M
-28.40%-93.06M
Gross profit
75.37%306.99M
34.68%409.55M
3.89%175.05M
7.63%304.08M
21.55%168.5M
10.40%282.52M
28.15%138.62M
41.93%255.89M
37.10%108.17M
13.72%180.29M
Selling expenses
-19.57%-97.34M
-3.53%-174.3M
6.37%-81.4M
-0.23%-168.35M
-49.21%-86.94M
-56.48%-167.97M
-41.92%-58.27M
-52.56%-107.34M
-32.62%-41.06M
-81.47%-70.36M
Administrative expenses
-12.82%-120.17M
-16.98%-213.44M
-33.73%-106.52M
-35.65%-182.46M
-41.44%-79.65M
-48.89%-134.51M
-54.85%-56.31M
-63.50%-90.34M
-38.98%-36.37M
-36.16%-55.26M
Research and development expenses
-14.01%-236.38M
-10.95%-432.83M
-16.74%-207.33M
-8.84%-390.1M
-1.41%-177.61M
-36.07%-358.4M
-51.69%-175.13M
-41.60%-263.4M
-83.73%-115.45M
-151.12%-186.02M
Revaluation surplus
-226.82%-113.51M
131.54%43.46M
24.21%-34.73M
113.46%18.77M
-2,764.00%-45.82M
-74.32%-139.43M
98.00%-1.6M
---79.98M
---79.98M
----
-Changes in the fair value of other assets
-226.82%-113.51M
131.54%43.46M
24.21%-34.73M
113.46%18.77M
-2,764.00%-45.82M
-74.32%-139.43M
98.00%-1.6M
---79.98M
---79.98M
----
Impairment and provision
-1,646.64%-41.34M
-30.15%-16.44M
-54.20%-2.37M
---12.63M
-24.70%-1.54M
----
---1.23M
----
----
----
-Other impairment is provision
-1,646.64%-41.34M
-30.15%-16.44M
-54.20%-2.37M
---12.63M
-24.70%-1.54M
----
---1.23M
----
----
----
Operating interest expense
----
----
----
----
---3.3M
56.22%-2.38M
----
-595.52%-5.43M
-1,065.37%-4.51M
---781K
Special items of operating profit
339.66%110.4M
393.55%60.52M
835.07%25.11M
189.29%12.26M
-170.55%-3.42M
-54.41%4.24M
-56.10%4.84M
-54.86%9.3M
99.46%11.03M
9.44%20.6M
Operating profit
17.58%-191.36M
22.69%-323.47M
-1.05%-232.19M
18.90%-418.42M
-54.13%-229.78M
-83.40%-515.93M
5.74%-149.08M
-152.22%-281.31M
-340.32%-158.17M
-585.91%-111.53M
Financing cost
-14.15%-14.23M
-107.33%-27.51M
---12.46M
---13.27M
----
----
---1.14M
----
----
----
Share of profits of associates
----
----
----
----
----
----
----
-94.48%-599K
-125.90%-314K
-53.23%-308K
Special items of earning before tax
----
----
----
----
----
-20,614.29%-1.44M
----
100.38%7K
177.46%433K
---1.85M
Earning before tax
15.97%-205.59M
18.70%-350.98M
-6.47%-244.65M
16.56%-431.69M
-52.96%-229.78M
-83.53%-517.36M
4.95%-150.22M
-147.95%-281.9M
-331.60%-158.05M
-600.84%-113.69M
Tax
-809.69%-10.04M
-211.37%-4.14M
71.05%-1.1M
485.79%3.72M
35.65%-3.81M
-302.10%-964K
-140.66%-5.93M
112.47%477K
-174.97%-2.46M
-97.11%-3.83M
After-tax profit from continuing operations
12.26%-215.63M
17.02%-355.12M
-5.21%-245.76M
17.43%-427.97M
-49.59%-233.59M
-84.18%-518.33M
2.72%-156.15M
-139.48%-281.42M
-381.50%-160.51M
-666.10%-117.52M
Earning after tax
12.26%-215.63M
17.02%-355.12M
-5.21%-245.76M
17.43%-427.97M
-49.59%-233.59M
-84.18%-518.33M
2.72%-156.15M
-139.48%-281.42M
-381.50%-160.51M
-666.10%-117.52M
Minority profit
73.38%-40.52M
-29.10%-259.64M
-55.15%-152.18M
-26.00%-201.12M
-50.83%-98.08M
-108.71%-159.62M
-37.14%-65.03M
-271.18%-76.48M
-691.73%-47.42M
-4,408.53%-20.6M
Profit attributable to shareholders
-87.13%-175.12M
57.91%-95.48M
30.94%-93.58M
36.76%-226.85M
-48.71%-135.51M
-75.03%-358.71M
19.43%-91.12M
-111.48%-204.95M
-313.56%-113.09M
-556.79%-96.91M
Basic earnings per share
-86.26%-0.0827
58.13%-0.0453
31.48%-0.0444
38.77%-0.1082
-40.56%-0.0648
-63.91%-0.1767
23.29%-0.0461
-106.12%-0.1078
-306.08%-0.0601
-543.22%-0.0523
Diluted earnings per share
-86.26%-0.0827
58.13%-0.0453
31.48%-0.0444
38.77%-0.1082
-40.56%-0.0648
-63.91%-0.1767
23.29%-0.0461
-106.12%-0.1078
-306.08%-0.0601
-554.78%-0.0523
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024 (FY)Dec 31, 2023 (Q6)Jun 30, 2023 (FY)Dec 31, 2022 (Q6)Jun 30, 2022 (FY)Dec 31, 2021 (Q6)Jun 30, 2021 (FY)Dec 31, 2020 (Q6)Jun 30, 2020 (FY)Dec 31, 2019
Turnover 43.46%561.37M 34.17%839.53M 26.40%391.31M 27.67%625.7M 34.86%309.59M 25.39%490.1M 37.97%229.57M 42.98%390.85M 36.53%166.39M 18.33%273.35M
Operating income 43.46%561.37M 34.17%839.53M 26.40%391.31M 27.67%625.7M 34.86%309.59M 25.39%490.1M 37.97%229.57M 42.98%390.85M 36.53%166.39M 18.33%273.35M
Cost of sales -17.63%-254.39M -33.69%-429.98M -53.28%-216.26M -54.94%-321.62M -55.13%-141.09M -53.82%-207.58M -56.21%-90.95M -45.01%-134.95M -35.46%-58.22M -28.40%-93.06M
Operating expenses -17.63%-254.39M -33.69%-429.98M -53.28%-216.26M -54.94%-321.62M -55.13%-141.09M -53.82%-207.58M -56.21%-90.95M -45.01%-134.95M -35.46%-58.22M -28.40%-93.06M
Gross profit 75.37%306.99M 34.68%409.55M 3.89%175.05M 7.63%304.08M 21.55%168.5M 10.40%282.52M 28.15%138.62M 41.93%255.89M 37.10%108.17M 13.72%180.29M
Selling expenses -19.57%-97.34M -3.53%-174.3M 6.37%-81.4M -0.23%-168.35M -49.21%-86.94M -56.48%-167.97M -41.92%-58.27M -52.56%-107.34M -32.62%-41.06M -81.47%-70.36M
Administrative expenses -12.82%-120.17M -16.98%-213.44M -33.73%-106.52M -35.65%-182.46M -41.44%-79.65M -48.89%-134.51M -54.85%-56.31M -63.50%-90.34M -38.98%-36.37M -36.16%-55.26M
Research and development expenses -14.01%-236.38M -10.95%-432.83M -16.74%-207.33M -8.84%-390.1M -1.41%-177.61M -36.07%-358.4M -51.69%-175.13M -41.60%-263.4M -83.73%-115.45M -151.12%-186.02M
Revaluation surplus -226.82%-113.51M 131.54%43.46M 24.21%-34.73M 113.46%18.77M -2,764.00%-45.82M -74.32%-139.43M 98.00%-1.6M ---79.98M ---79.98M ----
-Changes in the fair value of other assets -226.82%-113.51M 131.54%43.46M 24.21%-34.73M 113.46%18.77M -2,764.00%-45.82M -74.32%-139.43M 98.00%-1.6M ---79.98M ---79.98M ----
Impairment and provision -1,646.64%-41.34M -30.15%-16.44M -54.20%-2.37M ---12.63M -24.70%-1.54M ---- ---1.23M ---- ---- ----
-Other impairment is provision -1,646.64%-41.34M -30.15%-16.44M -54.20%-2.37M ---12.63M -24.70%-1.54M ---- ---1.23M ---- ---- ----
Operating interest expense ---- ---- ---- ---- ---3.3M 56.22%-2.38M ---- -595.52%-5.43M -1,065.37%-4.51M ---781K
Special items of operating profit 339.66%110.4M 393.55%60.52M 835.07%25.11M 189.29%12.26M -170.55%-3.42M -54.41%4.24M -56.10%4.84M -54.86%9.3M 99.46%11.03M 9.44%20.6M
Operating profit 17.58%-191.36M 22.69%-323.47M -1.05%-232.19M 18.90%-418.42M -54.13%-229.78M -83.40%-515.93M 5.74%-149.08M -152.22%-281.31M -340.32%-158.17M -585.91%-111.53M
Financing cost -14.15%-14.23M -107.33%-27.51M ---12.46M ---13.27M ---- ---- ---1.14M ---- ---- ----
Share of profits of associates ---- ---- ---- ---- ---- ---- ---- -94.48%-599K -125.90%-314K -53.23%-308K
Special items of earning before tax ---- ---- ---- ---- ---- -20,614.29%-1.44M ---- 100.38%7K 177.46%433K ---1.85M
Earning before tax 15.97%-205.59M 18.70%-350.98M -6.47%-244.65M 16.56%-431.69M -52.96%-229.78M -83.53%-517.36M 4.95%-150.22M -147.95%-281.9M -331.60%-158.05M -600.84%-113.69M
Tax -809.69%-10.04M -211.37%-4.14M 71.05%-1.1M 485.79%3.72M 35.65%-3.81M -302.10%-964K -140.66%-5.93M 112.47%477K -174.97%-2.46M -97.11%-3.83M
After-tax profit from continuing operations 12.26%-215.63M 17.02%-355.12M -5.21%-245.76M 17.43%-427.97M -49.59%-233.59M -84.18%-518.33M 2.72%-156.15M -139.48%-281.42M -381.50%-160.51M -666.10%-117.52M
Earning after tax 12.26%-215.63M 17.02%-355.12M -5.21%-245.76M 17.43%-427.97M -49.59%-233.59M -84.18%-518.33M 2.72%-156.15M -139.48%-281.42M -381.50%-160.51M -666.10%-117.52M
Minority profit 73.38%-40.52M -29.10%-259.64M -55.15%-152.18M -26.00%-201.12M -50.83%-98.08M -108.71%-159.62M -37.14%-65.03M -271.18%-76.48M -691.73%-47.42M -4,408.53%-20.6M
Profit attributable to shareholders -87.13%-175.12M 57.91%-95.48M 30.94%-93.58M 36.76%-226.85M -48.71%-135.51M -75.03%-358.71M 19.43%-91.12M -111.48%-204.95M -313.56%-113.09M -556.79%-96.91M
Basic earnings per share -86.26%-0.0827 58.13%-0.0453 31.48%-0.0444 38.77%-0.1082 -40.56%-0.0648 -63.91%-0.1767 23.29%-0.0461 -106.12%-0.1078 -306.08%-0.0601 -543.22%-0.0523
Diluted earnings per share -86.26%-0.0827 58.13%-0.0453 31.48%-0.0444 38.77%-0.1082 -40.56%-0.0648 -63.91%-0.1767 23.29%-0.0461 -106.12%-0.1078 -306.08%-0.0601 -554.78%-0.0523
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards HKAS HKAS HKAS HKAS HKAS HKAS HKAS HKAS HKAS HKAS
Audit Opinions -- Unqualified Opinion -- Unqualified Opinion -- -- -- -- -- Unqualified Opinion
Auditor -- Ernst & Young -- Ernst & Young -- Ernst & Young -- Ernst & Young -- Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data